Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...

Anne Wojcicki, 23andMe’s co-founder and chief executive, has said she intends to take the company private and will not consider a third-party takeover. “We are committed to protecting customer data ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

CEO Anne Wojcicki has said she intends to take the company private and is not considering third-party takeover proposals.

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...

CEO Anne Wojcicki, who holds roughly half of the voting power, is attempting to take the company private. In September, seven ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...